| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |